The Local Antibody Mucosal Brush Diagnostic (LAMB-Dx) is a platform technology that allows for accurate detection and diagnosis of diseases, including airborne and food allergies. The first LAMB-Dx product is a local allergy diagnostic that will conveniently and accurately diagnose allergies using a small sample of cells that are painlessly collected with a soft brush from the inside of the nose or mouth. The patented LAMB-Dx uses a proprietary assay to detect antigen-specific IgE from epithelial mucosal cells, which no other test can do. The LAMB-Dx test results can be used to guide targeted patient treatments, such as immunotherapy. Importantly, LAMB-Dx is designed to correctly diagnose the many patients who have results from blood or skin testing which are inaccurate or inconsistent with their symptoms. LAMB-Dx is gentle, rapid and needle-free, making it ideal for the pediatric population. 



Through clinical data gathered by 4 proof-of-concept studies published in peer-reviewed journals, the utility of the LAMB-Dx test has been demonstrated for both food and respiratory allergies. Currently, Immunovent is optimizing the protocols for patient sample collection, preparation, processing, and testing at a New York City-based biomedical research center and at our laboratory located in the Harlem Biospace. We anticipate commencing larger-scale clinical trials this year and expect an initial launch of our first allergy diagnostic by 2016. For more information, please visit the clinical tab.